These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28070056)
21. Ketosis-prone diabetes mellitus in an obese adolescent: A case report. Tan H; Wang C; Yu Y Medicine (Baltimore); 2019 Jun; 98(25):e16076. PubMed ID: 31232947 [TBL] [Abstract][Full Text] [Related]
22. Characterization of residual β cell function in long-standing type 1 diabetes. Sherr JL; Ghazi T; Wurtz A; Rink L; Herold KC Diabetes Metab Res Rev; 2014 Feb; 30(2):154-62. PubMed ID: 24115337 [TBL] [Abstract][Full Text] [Related]
23. Distinct diagnostic criteria of fulminant type 1 diabetes based on serum C-peptide response and HbA1c levels at onset. Tanaka S; Endo T; Aida K; Shimura H; Yokomori N; Kaneshige M; Furuya F; Amemiya S; Mochizuki M; Nakanishi K; Kobayashi T Diabetes Care; 2004 Aug; 27(8):1936-41. PubMed ID: 15277420 [TBL] [Abstract][Full Text] [Related]
24. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral. Kusuki K; Suzuki S; Mizuno Y Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673 [TBL] [Abstract][Full Text] [Related]
25. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Koga M; Murai J; Saito H; Kasayama S Diabetes Care; 2010 Feb; 33(2):270-2. PubMed ID: 19846794 [TBL] [Abstract][Full Text] [Related]
26. Effect of sitagliptin on glycemic control and beta cell function in Japanese patients given basal-supported oral therapy for type 2 diabetes. Asai S; Ohta A; Kato H; Sada Y; Nagai Y; Kondo A; Sasaoka T; Tanaka Y Endocr J; 2014; 61(12):1213-20. PubMed ID: 25231694 [TBL] [Abstract][Full Text] [Related]
27. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335 [TBL] [Abstract][Full Text] [Related]
28. Serum levels of leptin and changes during the course of recovery from diabetic ketoacidosis. Nakamura T; Nagasaka S; Ishikawa S; Fujibayashi K; Kawakami A; Rokkaku K; Hayashi H; Saito T; Kusaka I; Higashiyama M; Saito T Diabetes Res Clin Pract; 1999 Oct; 46(1):57-63. PubMed ID: 10580617 [TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of and therapy for fulminant type 1 diabetes mellitus]. Imakawa A; Hanafusa T Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1129-34. PubMed ID: 16846065 [No Abstract] [Full Text] [Related]
30. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial. Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482 [TBL] [Abstract][Full Text] [Related]
31. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Umpierrez GE; Clark WS; Steen MT Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964 [TBL] [Abstract][Full Text] [Related]
32. Management of ketosis-prone type 2 diabetes mellitus. Smolenski S; George NM J Am Assoc Nurse Pract; 2019 Jul; 31(7):430-436. PubMed ID: 30829978 [TBL] [Abstract][Full Text] [Related]
33. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB; Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743 [TBL] [Abstract][Full Text] [Related]
34. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children. Elamin A; Omer MI; Tuvemo T Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856 [TBL] [Abstract][Full Text] [Related]
35. Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes. Abdelgani S; Puckett C; Adams J; Triplitt C; DeFronzo RA; Abdul-Ghani M J Clin Endocrinol Metab; 2021 Nov; 106(12):3497-3504. PubMed ID: 34343296 [TBL] [Abstract][Full Text] [Related]
36. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162 [TBL] [Abstract][Full Text] [Related]
37. Children with type 1 diabetes of early age at onset - immune and metabolic phenotypes. Sales Luis M; Alcafache M; Ferreira S; Fitas AL; Simões Pereira J; Caramalho Í; Lopes L; Limbert C J Pediatr Endocrinol Metab; 2019 Sep; 32(9):935-941. PubMed ID: 31280235 [TBL] [Abstract][Full Text] [Related]
38. A rare case of a mother with gestational diabetes complicated with fulminant type 1 diabetes mellitus post-delivery. Ting Tai Y; Mohd Noor N J R Coll Physicians Edinb; 2022 Jun; 52(2):120-123. PubMed ID: 36147001 [TBL] [Abstract][Full Text] [Related]
39. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes. Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319 [TBL] [Abstract][Full Text] [Related]
40. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment. Hsieh SD; Akanuma Y; Takaku F Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]